These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1727133)

  • 1. Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow.
    Natori Y; Moriguchi M; Fujiwara S; Takeshita I; Fukui M; Iwaki T; Kanaide H
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):120-7. PubMed ID: 1727133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW; McCreedy SA
    Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.
    Tozer GM; Prise VE; Chaplin DJ
    Cancer Res; 1997 Mar; 57(5):948-55. PubMed ID: 9041200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus.
    Boeckxstaens GE; Pelckmans PA; Bogers JJ; Bult H; De Man JG; Oosterbosch L; Herman AG; Van Maercke YM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):441-7. PubMed ID: 1671594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
    Joly GA; Ayres M; Chelly F; Kilbourn RG
    Biochem Biophys Res Commun; 1994 Feb; 199(1):147-54. PubMed ID: 7510104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature.
    Bertuglia S; Colantuoni A; Intaglietta M
    Microvasc Res; 1995 Sep; 50(2):162-74. PubMed ID: 8538497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and N omega nitro L-arginine methyl ester.
    Winn MJ; Asante NK; Ku DD
    J Pharmacol Exp Ther; 1993 Jan; 264(1):265-70. PubMed ID: 8423529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts.
    Kirkebøen KA; Naess PA; Offstad J; Ilebekk A
    Am J Physiol; 1994 Apr; 266(4 Pt 2):H1516-27. PubMed ID: 8184929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
    Schmidt K; Klatt P; Mayer B
    Mol Pharmacol; 1993 Sep; 44(3):615-21. PubMed ID: 7690451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity.
    Stojanovic T; Gröne HJ; Gieseler RK; Klanke B; Schlemminger R; Tsikas D; Gröne EF
    Lab Invest; 1996 Feb; 74(2):496-512. PubMed ID: 8780167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of non-arginine compounds with the endothelium-derived relaxing factor inhibitor, NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1992 Feb; 260(2):676-9. PubMed ID: 1310739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG-monomethyl-L-arginine-induced pressor response at developmental and established stages in spontaneously hypertensive rats.
    Yamazaki J; Fujita N; Nagao T
    J Pharmacol Exp Ther; 1991 Oct; 259(1):52-7. PubMed ID: 1920134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
    Bedarida GV; Kim D; Blaschke TF; Hoffman BB
    Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
    Calver A; Collier J; Moncada S; Vallance P
    J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gut.
    Boeckxstaens GE; Pelckmans PA; Bult H; De Man JG; Herman AG; van Maercke YM
    Br J Pharmacol; 1991 Feb; 102(2):434-8. PubMed ID: 1673072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-NMMA in brain microcirculation of mice is inhibited by blockade of cyclooxygenase and by superoxide dismutase.
    Rosenblum WI; Nishimura H; Nelson GH
    Am J Physiol; 1992 May; 262(5 Pt 2):H1343-9. PubMed ID: 1590436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of theophylline on the selective increases in intratumoral blood flow induced by intracarotid infusion of adenosine and adenosine triphosphate in C6 glioma-transplanted rat brains.
    Natori Y; Baba T; Moriguchi M; Takeshita I; Fukui M
    Surg Neurol; 1992 Jan; 37(1):8-14. PubMed ID: 1727090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.